AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
ANTIOXIDANT CONTENT IN LOW-DENSITY-LIPOPROTEIN AND LIPOPROTEIN OXIDATION IN-VIVO AND IN-VITRO
Authors: TERTOV VV SOBENIN IA KAPLUN VV OREKHOV AN
Citation: Vv. Tertov et al., ANTIOXIDANT CONTENT IN LOW-DENSITY-LIPOPROTEIN AND LIPOPROTEIN OXIDATION IN-VIVO AND IN-VITRO, Free radical research, 29(2), 1998, pp. 165-173
IN-VIVO OXIDIZED LOW-DENSITY-LIPOPROTEIN - DEGREE OF LIPOPROTEIN OXIDATION DOES NOT CORRELATE WITH ITS ATHEROGENIC PROPERTIES
Authors: TERTOV VV KAPLUN VV OREKHOV AN
Citation: Vv. Tertov et al., IN-VIVO OXIDIZED LOW-DENSITY-LIPOPROTEIN - DEGREE OF LIPOPROTEIN OXIDATION DOES NOT CORRELATE WITH ITS ATHEROGENIC PROPERTIES, Molecular and cellular biochemistry, 183(1-2), 1998, pp. 141-146
OPTIMIZATION OF THE ASSAY FOR SIALIC-ACID DETERMINATION IN LOW-DENSITY-LIPOPROTEIN
Authors: SOBENIN IA TERTOV VV OREKHOV AN
Citation: Ia. Sobenin et al., OPTIMIZATION OF THE ASSAY FOR SIALIC-ACID DETERMINATION IN LOW-DENSITY-LIPOPROTEIN, Journal of lipid research, 39(11), 1998, pp. 2293-2299
LOW-DENSITY-LIPOPROTEIN MODIFICATION OCCURRING IN HUMAN PLASMA POSSIBLE MECHANISM OF IN-VIVO LIPOPROTEIN DESIALYLATION AS A PRIMARY STEP OFATHEROGENIC MODIFICATION
Authors: TERTOV VV KAPLUN VV SOBENIN IA OREKHOV AN
Citation: Vv. Tertov et al., LOW-DENSITY-LIPOPROTEIN MODIFICATION OCCURRING IN HUMAN PLASMA POSSIBLE MECHANISM OF IN-VIVO LIPOPROTEIN DESIALYLATION AS A PRIMARY STEP OFATHEROGENIC MODIFICATION, Atherosclerosis, 138(1), 1998, pp. 183-195
THE EFFECTS OF ANTIHYPERTENSIVE AGENTS ON ATHEROSCLEROSIS-RELATED PARAMETERS OF HUMAN AORTA INTIMAL CELLS
Authors: OREKHOV AN TERTOV VV PIVOVAROVA EM
Citation: An. Orekhov et al., THE EFFECTS OF ANTIHYPERTENSIVE AGENTS ON ATHEROSCLEROSIS-RELATED PARAMETERS OF HUMAN AORTA INTIMAL CELLS, Cardiology, 89(2), 1998, pp. 111-118
ANTIATHEROSCLEROTIC AND ANTIATHEROGENIC EFFECTS OF A CALCIUM-ANTAGONIST PLUS STATIN COMBINATION - AMLODIPINE AND LOVASTATIN
Authors: OREKHOV AN TERTOV VV SOBENIN IA AKHMEDZHANOV NM PIVOVARONA EM
Citation: An. Orekhov et al., ANTIATHEROSCLEROTIC AND ANTIATHEROGENIC EFFECTS OF A CALCIUM-ANTAGONIST PLUS STATIN COMBINATION - AMLODIPINE AND LOVASTATIN, International journal of cardiology, 62, 1997, pp. 67-77
IN-VITRO EFFECT OF GARLIC POWDER EXTRACT ON LIPID-CONTENT IN NORMAL AND ATHEROSCLEROTIC HUMAN AORTIC-CELLS
Authors: OREKHOV AN TERTOV VV
Citation: An. Orekhov et Vv. Tertov, IN-VITRO EFFECT OF GARLIC POWDER EXTRACT ON LIPID-CONTENT IN NORMAL AND ATHEROSCLEROTIC HUMAN AORTIC-CELLS, Lipids, 32(10), 1997, pp. 1055-1060
ANTI-ATHEROGENIC EFFECT OF CALCIUM-ANTAGONIST PLUS STATIN COTREATMENTREALIZES AT LIPOPROTEIN LEVEL
Authors: OREKHOV AN TERTOV VV SOBENIN IA PIVOVAROVA EM
Citation: An. Orekhov et al., ANTI-ATHEROGENIC EFFECT OF CALCIUM-ANTAGONIST PLUS STATIN COTREATMENTREALIZES AT LIPOPROTEIN LEVEL, Atherosclerosis, 134(1-2), 1997, pp. 59-59
COVALENT BINDING OF LIPIDS TO APOLIPOPROTEIN-B AS A MARKER OF LDL OXIDATION
Authors: KAPLUN VV TERTOV VV OREKHOV AN
Citation: Vv. Kaplun et al., COVALENT BINDING OF LIPIDS TO APOLIPOPROTEIN-B AS A MARKER OF LDL OXIDATION, Atherosclerosis, 134(1-2), 1997, pp. 213-213
IN-VIVO AND IN-VITRO OXIDATION OF NATIVE AND MODIFIED LDL - CORRELATION WITH ANTIOXIDANT CONTENT
Authors: TERTOV VV KAPLUN VV SOBENIN IA OREKHOV AN
Citation: Vv. Tertov et al., IN-VIVO AND IN-VITRO OXIDATION OF NATIVE AND MODIFIED LDL - CORRELATION WITH ANTIOXIDANT CONTENT, Atherosclerosis, 134(1-2), 1997, pp. 218-218
ATHEROGENICITY OF LOW-DENSITY-LIPOPROTEIN DOES NOT CORRELATE WITH THEDEGREE OF ITS OXIDATION
Authors: TERTOV VV KAPLUN VV OREKHOV AN
Citation: Vv. Tertov et al., ATHEROGENICITY OF LOW-DENSITY-LIPOPROTEIN DOES NOT CORRELATE WITH THEDEGREE OF ITS OXIDATION, Atherosclerosis, 134(1-2), 1997, pp. 227-227
METABOLISM OF NATIVE AND MODIFIED LDL IN HUMAN INTIMAL SMOOTH-MUSCLE CELLS
Authors: TERTOV VV
Citation: Vv. Tertov, METABOLISM OF NATIVE AND MODIFIED LDL IN HUMAN INTIMAL SMOOTH-MUSCLE CELLS, Atherosclerosis, 134(1-2), 1997, pp. 253-253
APO-B-BOUND LIPIDS AS A PARAMETER REFLECTING THE LEVEL OF LDL OXIDATION
Authors: KAPLUN VV TERTOV VV OREKHOV AV
Citation: Vv. Kaplun et al., APO-B-BOUND LIPIDS AS A PARAMETER REFLECTING THE LEVEL OF LDL OXIDATION, Atherosclerosis, 130, 1997, pp. 47-47
MULTIPLE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN OCCURRING IN HUMAN PLASMA
Authors: TERTOV VV KAPLUN VV SOBENIN IA OREKHOV AN
Citation: Vv. Tertov et al., MULTIPLE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN OCCURRING IN HUMAN PLASMA, Atherosclerosis, 130, 1997, pp. 59-59
ANTI-ATHEROGENIC EFFECT OF CALCIUM-ANTAGONIST PLUS STATIN COMBINATION- AMLODIPINE AND LOVASTATIN
Authors: OREKHOV AN TERTOV VV SOBENIN IA PIVOVAROVA EM
Citation: An. Orekhov et al., ANTI-ATHEROGENIC EFFECT OF CALCIUM-ANTAGONIST PLUS STATIN COMBINATION- AMLODIPINE AND LOVASTATIN, Atherosclerosis, 130, 1997, pp. 116-116
SIMILARITY BETWEEN NATURALLY-OCCURRING MODIFIED DESIALYLATED, ELECTRONEGATIVE AND AORTIC LOW-DENSITY-LIPOPROTEIN
Authors: TERTOV VV SOBENIN IA OREKHOV AN
Citation: Vv. Tertov et al., SIMILARITY BETWEEN NATURALLY-OCCURRING MODIFIED DESIALYLATED, ELECTRONEGATIVE AND AORTIC LOW-DENSITY-LIPOPROTEIN, Free radical research, 25(4), 1996, pp. 313-319
GARLIC POWDER TABLETS REDUCE ATHEROGENICITY OF LOW-DENSITY-LIPOPROTEIN - A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
Authors: OREKHOV AN PIVOVAROVA EM TERTOV VV
Citation: An. Orekhov et al., GARLIC POWDER TABLETS REDUCE ATHEROGENICITY OF LOW-DENSITY-LIPOPROTEIN - A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 6(1), 1996, pp. 21-31
CHARACTERISTICS OF LOW-DENSITY-LIPOPROTEIN ISOLATED FROM CIRCULATING IMMUNE-COMPLEXES
Authors: TERTOV VV SOBENIN IA OREKHOV AN JAAKKOLA O SOLAKIVI T NIKKARI T
Citation: Vv. Tertov et al., CHARACTERISTICS OF LOW-DENSITY-LIPOPROTEIN ISOLATED FROM CIRCULATING IMMUNE-COMPLEXES, Atherosclerosis, 122(2), 1996, pp. 191-199
ATHEROGENIC MODIFIED LDL IN DIABETES
Authors: SOBENIN IA TERTOV VV OREKHOV AN
Citation: Ia. Sobenin et al., ATHEROGENIC MODIFIED LDL IN DIABETES, Diabetes, 45, 1996, pp. 35-39
DIRECT ANTI-ATHEROSCLEROSIS-RELATED EFFECTS OF GARLIC
Authors: OREKHOV AN TERTOV VV SOBENIN IA PIVOVAROVA EM
Citation: An. Orekhov et al., DIRECT ANTI-ATHEROSCLEROSIS-RELATED EFFECTS OF GARLIC, Annals of medicine, 27(1), 1995, pp. 63-65
NATURALLY-OCCURRING MODIFIED LOW-DENSITY LIPOPROTEINS ARE SIMILAR IF NOT IDENTICAL - MORE ELECTRONEGATIVE AND DESIALYLATED LIPOPROTEIN SUBFRACTIONS
Authors: TERTOV VV BITTOLOBON G SOBENIN IA CAZZOLATO G OREKHOV AN AVOGARO P
Citation: Vv. Tertov et al., NATURALLY-OCCURRING MODIFIED LOW-DENSITY LIPOPROTEINS ARE SIMILAR IF NOT IDENTICAL - MORE ELECTRONEGATIVE AND DESIALYLATED LIPOPROTEIN SUBFRACTIONS, Experimental and molecular pathology, 62(3), 1995, pp. 166-172
MODIFIED (DESIALYLATED) LOW-DENSITY-LIPOPROTEIN MEASURED IN SERUM BY LECTIN-SORBENT ASSAY
Authors: TERTOV VV SOBENIN IA OREKHOV AN
Citation: Vv. Tertov et al., MODIFIED (DESIALYLATED) LOW-DENSITY-LIPOPROTEIN MEASURED IN SERUM BY LECTIN-SORBENT ASSAY, Clinical chemistry, 41(7), 1995, pp. 1018-1021
APOLIPOPROTEIN B-BOUND LIPIDS AS A MARKER FOR EVALUATION OF LOW-DENSITY-LIPOPROTEIN OXIDATION IN-VIVO
Authors: TERTOV VV KAPLUN VV DVORYANTSEV SN OREKHOV AN
Citation: Vv. Tertov et al., APOLIPOPROTEIN B-BOUND LIPIDS AS A MARKER FOR EVALUATION OF LOW-DENSITY-LIPOPROTEIN OXIDATION IN-VIVO, Biochemical and biophysical research communications, 214(2), 1995, pp. 608-613
CHARACTERIZATION OF CHEMICAL-COMPOSITION OF NATIVE AND MODIFIED LOW-DENSITY-LIPOPROTEIN OCCURRING IN THE BLOOD OF DIABETIC-PATIENTS
Authors: SOBENIN IA TERTOV VV OREKHOV AN
Citation: Ia. Sobenin et al., CHARACTERIZATION OF CHEMICAL-COMPOSITION OF NATIVE AND MODIFIED LOW-DENSITY-LIPOPROTEIN OCCURRING IN THE BLOOD OF DIABETIC-PATIENTS, International angiology, 13(1), 1994, pp. 78-83
EFFECT OF LIPOPROTEIN(A) ON LIPID-METABOLISM OF CULTURED HUMAN INTIMAL AORTIC-CELLS
Authors: TERTOV VV OREKHOV AN
Citation: Vv. Tertov et An. Orekhov, EFFECT OF LIPOPROTEIN(A) ON LIPID-METABOLISM OF CULTURED HUMAN INTIMAL AORTIC-CELLS, Chemistry and physics of lipids, 67-8, 1994, pp. 161-166
Risultati: 1-25 | 26-33